Question 1

What is S1 Biopharma?

Accepted Answer

S1 Biopharma is a biopharmaceutical company focused on developing novel treatments for sexual dysfunction, particularly hypoactive sexual desire disorder (HSDD) in women.

Question 2

What is Lorexys?

Accepted Answer

Lorexys is S1 Biopharma's lead product candidate for the treatment of HSDD in premenopausal women. It is a first-in-class medicine that has been granted patents in Europe and Asia for this indication.

Question 3

What other products are in S1 Biopharma's pipeline?

Accepted Answer

In addition to Lorexys, S1 Biopharma's pipeline includes S1B-307 and S1B-3006, which are being developed for the treatment of other forms of sexual dysfunction, such as arousal disorder and orgasmic disorder.

Question 4

What is the status of S1 Biopharma's clinical development programs?

Accepted Answer

S1 Biopharma has conducted a dose-finding study of Lorexys for the treatment of HSDD in premenopausal women, and has presented expanded analysis of the phase 2a data at the 2019 ISSWSH/ISSM joint meeting.

Question 5

How is S1 Biopharma working to address sexual wellness?

Accepted Answer

S1 Biopharma is taking a new, holistic approach to addressing sexual dysfunction, focusing not only on developing first-in-class medicines, but also on understanding the broader aspects of sexual wellness and dysfunction.

S1 Biopharma

Company Overview

Company Name

Address

Website

Phone

About S1 Biopharma

Similar Companies

Frequently Asked Questions about S1 Biopharma

What is S1 Biopharma?

What is Lorexys?

What other products are in S1 Biopharma's pipeline?

What is the status of S1 Biopharma's clinical development programs?

How is S1 Biopharma working to address sexual wellness?

Technologies Used

Social Profiles